Zentalis Pharmaceuticals (ZNTL) Intangibles (2019 - 2021)

Zentalis Pharmaceuticals' Intangibles history runs 3 years deep, the most recent figure standing at $8.8 million for Q2 2021.

• In Q2 2021, Intangibles changed 0.0% year-over-year to $8.8 million; the TTM figure through Jun 2021 stood at $8.8 million (changed 0.0% YoY), while the FY2020 annual figure was $8.8 million, changed 0.0% from the prior year.
• Intangibles for Q2 2021 stood at $8.8 million, roughly flat from $8.8 million in the prior quarter.
• The five-year high for Intangibles was $8.8 million in Q4 2019, with the low at $8.8 million in Q4 2019.
• The 3-year median for Intangibles is $8.8 million (2019), against an average of $8.8 million.
• Peak annual rise in Intangibles reached 0.0% in 2020, while the deepest fall reached 0.0% in 2020.
• Zentalis Pharmaceuticals' Intangibles stood at $8.8 million in 2019, then changed by 0.0% to $8.8 million in 2020, then changed by 0.0% to $8.8 million in 2021.
• Business Quant data shows ZNTL's Intangibles at $8.8 million in Q2 2021, $8.8 million in Q1 2021, and $8.8 million in Q4 2020.